4.8 Review

Inducing broad-based immunity against viruses with pandemic potential

Journal

IMMUNITY
Volume 55, Issue 5, Pages 738-748

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2022.04.010

Keywords

-

Categories

Funding

  1. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [U19AI142790, P01AI165072, 75N93021C00016, 75N93019C00065]
  2. Bill and Melinda Gates Foundation [INV-006133]
  3. Bill and Melinda Gates Foundation [INV-006133] Funding Source: Bill and Melinda Gates Foundation

Ask authors/readers for more resources

Investing in research to uncover mechanisms of broad-based immunity and developing vaccines that elicit both broadly protective antibodies and T cells is crucial to mitigate the impact of the next viral pandemic.
The brutal toll of another viral pandemic can be blunted by investing now in research that uncovers mecha-nisms of broad-based immunity so we may have vaccines and therapeutics at the ready. We do not know exactly what pathogen may trigger the next wave or next pandemic. We do know, however, that the human immune system must respond and must be bolstered with effective vaccines and other therapeutics to preserve lives and livelihoods. These countermeasures must focus on features conserved among families of pathogens in order to be responsive against something yet to emerge. Here, we focus on immunological ap-proaches to mitigate the impact of the next emerging virus pandemic by developing vaccines that elicit both broadly protective antibodies and T cells. Identifying human immune mechanisms of broad protection against virus families with pandemic potential will be our best defense for humanity in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available